1-2 of 2
Carlos Fernández de Larrea
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P22: PVR (CD155) epigenetic status mediates adoptive cell therapy and anti-TIGIT response in Multiple Myeloma

Laura Martinez-Verbo, Lorea Villanueva, Pere Llinàs-Arias, Carlos A. García-Prieto, David Piñeyro, Aina Oliver-Caldes, Almudena García-Ortiz, Antonio Valeri, Carlos Fernández de Larrea, Joaquín Martínez-López, Gerardo Ferrer, Manel Esteller
Journal: Blood Cancer Discovery
Blood Cancer Discov (2024) 5 (2_Supplement): P22.
https://doi.org/10.1158/2643-3249.BCDSYMP24-P22
Published: 04 March 2024
View articletitled, Abstract P22: PVR (CD155) epigenetic status mediates adoptive cell therapy and anti-TIGIT response in Multiple Myeloma
Journal Articles

Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape–Driven Relapse in Multiple Myeloma

Carlos Fernández de Larrea, Mette Staehr, Andrea V. Lopez, Khong Y. Ng, Yunxin Chen, William D. Godfrey, Terence J. Purdon, Vladimir Ponomarev, Hans-Guido Wendel, Renier J. Brentjens, Eric L. Smith
Journal: Blood Cancer Discovery
Blood Cancer Discov (2020) 1 (2): 146–154.
https://doi.org/10.1158/2643-3230.BCD-20-0020
Published: 01 September 2020
View articletitled, Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape–Driven Relapse in Multiple Myeloma
Open the PDF for Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape–Driven Relapse in Multiple Myeloma in another window
Includes: Supplementary data